- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06518525
The Effects Of Pilates-Based Tele-Exercise In Primary Dysmenorrhea
February 24, 2025 updated by: Derya Azim
The Effects Of Pilates-Based Tele-Exercise On Physical And Mental Health In Primary Dysmenorrhea
In this study, the investigators will aim to investigate the effects of Pilates-based tele-exercise on the physical and mental health of women with primary dysmenorrhea.
The study will include 22 volunteers diagnosed with primary dysmenorrhea.
Participants will be randomly divided into two groups.
The first group will undergo Pilates-based tele-exercises (6 weeks/2 days/50 minutes) (PTTE, n=11).
The second group will be a non-intervention control group (CG, n=11).
Pain severity will be assessed using the Visual Analog Scale (VAS), and menstrual information will be evaluated using the Menstrual Symptom Questionnaire (MSQ), Menstrual Attitude Questionnaire (MAQ), and Functional and Emotional Dysmenorrhea Scale (FEDS).
Quality of life will be assessed using the Nottingham Health Profile (NHP).
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
In this study, the investigators will aim to investigate the effects of Pilates-based tele-exercise on the physical and mental health of women with primary dysmenorrhea.
The study will include 22 volunteers diagnosed with primary dysmenorrhea.
Participants will be randomly divided into two groups.
The first group will undergo Pilates-based tele-exercises (6 weeks/2 days/50 minutes) (PTTE, n=11).
The second group will be a non-intervention control group (CG, n=11).
Pain severity will be assessed using the Visual Analog Scale (VAS), and menstrual information will be evaluated using the Menstrual Symptom Questionnaire (MSQ), Menstrual Attitude Questionnaire (MAQ), and Functional and Emotional Dysmenorrhea Scale (FEDS).
Quality of life will be assessed using the Nottingham Health Profile (NHP).Inclusion criteria were determined as follows: being between 18-30 years old, diagnosed with primary dysmenorrhea during an ultrasound examination, having a PD pain score of 4-7 cm on the Visual Analog Scale (VAS), being able to attend Pilates sessions twice a week, not engaging in regular exercise, and having a regular menstrual cycle (30-35 days) and bleeding duration (3-10 days).
Exclusion criteria included being pregnant, having serious comorbidities (neurological, cardiovascular, and musculoskeletal disorders), and not willing to participate in the study.
Volunteers who agree to participate in the study will sign an informed consent form, after which they will be given the necessary information about the scales used in the assessment.
The scales will be filled out by the participants based on their previous menstrual experiences.
After the assessment, Pilates-based tele-rehabilitation exercises will be applied for 6 weeks.
At the end of the 6 weeks, assessments will be repeated in both groups.
The scales applied to both groups before and after the study will be uploaded to the Google Forms database and sent to the participants.
Study Type
Interventional
Enrollment (Actual)
22
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Bandırma
-
Balıkesir, Bandırma, Turkey
- Bandırma Onyedi Eylül University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Being between 18-30 years old,
- Diagnosed with primary dysmenorrhea during an ultrasound examination,
- Having a PD pain score of 4-7 cm on the Visual Analog Scale (VAS),
- Being able to attend Pilates sessions twice a week,
- Not engaging in regular exercise,
- Having a regular menstrual cycle (30-35 days) and a bleeding duration of 3-10 days,
Exclusion Criteria:
- Being pregnant,
- Having serious comorbidities (neurological, cardiovascular, and musculoskeletal disorders),
- Not willing to participate in the study,
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: control group
|
|
|
Experimental: pilates-based tele-exercises
Participants in the primary dysmenorrhea study group will be given a general introduction to Pilates-based tele-exercises, and they will be taught five essential elements that they should continuously practice during the exercise process.
These elements will be control, breathing, fluidity, precision, and centering.
They will be instructed on how to activate the core muscles, including the transverse abdominis, pelvic floor, and multifidus muscles, through isometric contractions while exhaling (centering).
The exercises will be conducted over 6 weeks, twice a week, with each session lasting 50 minutes.
The exercises, predetermined by the researcher, will be performed under the supervision of a physiotherapist.
Each session will be structured into warm-up exercises, main exercises, and cool-down exercises. .
|
pilates-based tele-exercises
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Sure, here is the English translation: Visual Analog Scale
Time Frame: Baseline and 6 weeks later
|
The Visual Analog Scale (VAS) was used to assess pain in the study.
The VAS is a horizontal or vertical line that is 10 cm in length.
At the beginning of the line, the phrase "no pain" is placed, and at the end, "unbearable pain" is written.
Participants are asked to mark the point on the line that corresponds to the severity of the pain they experience.
The distance between the point where the VAS value is the lowest and the point where the patient marked is measured, and the numerical value corresponding to the pain severity is recorded
|
Baseline and 6 weeks later
|
|
Nottingham Health Profile
Time Frame: Baseline and 6 weeks later
|
The Nottingham Health Profile (NHP) is a quality of life assessment questionnaire developed in 1987 to determine the degree to which individuals' perceived health problems affect their daily activities.
The Turkish version of the scale was developed and psychometrically evaluated by Küçükdeveci et al.
The NHP consists of six sub-dimensions: pain (8 items), emotional reactions (9 items), sleep (5 items), social isolation (5 items), physical activity (8 items), and energy (3 items).
The questionnaire is answered with 'yes' or 'no'.
Each section of the questionnaire is calculated separately; the sub-dimension score is obtained by summing the 'yes' responses to the items in each sub-dimension and dividing by the number of items in that sub-dimension, then multiplying by 100.
Each sub-dimension scores between 0 and 100, with higher scores indicating lower quality of life
|
Baseline and 6 weeks later
|
|
Menstrual Symptom Questionnaire
Time Frame: Baseline and 6 weeks later
|
he Menstrual Symptom Questionnaire (MSQ) was developed in English by Chesney and Tasto in 1975 to assess pain and other symptoms associated with menstruation.
The Turkish validity and reliability were completed by Güvenç et al. in 2014.
The scale consists of 24 items in total, in a 5-point Likert-type format.
It includes three sub-dimensions: 'Negative Effects/Somatic Complaints' (13 items), 'Pain Symptoms' (6 items), and 'Coping Methods' (3 items).
Participants are asked to rate the symptoms they experience during menstruation as 1 (never), 2 (rarely), 3 (sometimes), 4 (often), and 5 (always).
The score for each sub-dimension is calculated as the average of the total points of the items in that sub-dimension.
The total score of the MSQ is calculated by averaging the total points of all scale items; higher scores indicate greater severity of menstrual symptoms.
|
Baseline and 6 weeks later
|
|
Menstrual Attitude Questionnaire
Time Frame: Baseline and 6 weeks later
|
The Menstrual Attitude Questionnaire (MAQ) was developed by Brooks-Gunn and Ruble in 1980, and its validity and reliability in Turkey were established by Kulakaç et al. in 2008.
The Turkish version of the MAQ consists of 33 items and five sub-scales in a Likert-type format.
These sub-scales are 'Menstruation as a debilitating event' (12 items), 'Menstruation as a bothersome event' (6 items), 'Menstruation as a natural event' (5 items), 'Anticipation and prediction of menstruation' (5 items), and 'Denial of menstruation effects' (7 items).
Participants are asked to select one of the following options for each question: 1. Strongly disagree, 2. Disagree, 3. Neutral, 4. Agree, and 5. Strongly agree.
Higher average scores from the items, sub-dimensions, or the entire scale indicate a more positive attitude towards menstruation.
|
Baseline and 6 weeks later
|
|
Functional and Emotional Dysmenorrhea Scale
Time Frame: Baseline and 6 weeks later
|
The Functional and Emotional Dysmenorrhea Scale (FEDS) is used to measure functional and emotional health in dysmenorrhea.
It was developed by Li et al. in 2012, and its Turkish validity and reliability were established by Gün in 2014.
The FEDS consists of 14 items in total, with two sub-dimensions: functional dysmenorrhea and emotional dysmenorrhea.
Participants are asked to choose the option that best describes their condition for each item: 1.
Does not resemble my condition at all, 2. Does not quite resemble my condition, 3.
Both resembles and does not resemble my condition, 4. Somewhat resembles my condition, 5. Very much resembles my condition.
Higher scores indicate greater functional and emotional impact from dysmenorrhea.
|
Baseline and 6 weeks later
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Emine Atıcı, Okan University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 1, 2024
Primary Completion (Actual)
October 30, 2024
Study Completion (Actual)
November 30, 2024
Study Registration Dates
First Submitted
July 19, 2024
First Submitted That Met QC Criteria
July 19, 2024
First Posted (Actual)
July 24, 2024
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
February 24, 2025
Last Verified
February 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- B.30.2.AYD.0.00.00
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
There is no plan to make individual participant data (IPD) available for use by other researchers.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Primary Dysmenorrhea
-
Ankara UniversityThe Scientific and Technological Research Council of TurkeyNot yet recruiting
-
University of SharjahNot yet recruiting
-
Cairo UniversityRecruitingPrimary DysmenorrheaEgypt
-
Cairo UniversityCompletedPrimary DysmenorrheaEgypt
-
Camilo Jose Cela UniversityNot yet recruiting
-
Cairo UniversityNot yet recruitingPrimary DysmenorrheaEgypt
-
Rana Salem Abdelghany AliCompletedPrimary DysmenorrheaEgypt
-
University of HailHealth Education Research Foundation (HERF)Recruiting
-
Dr. Mehak NaeemUniversity of Health Sciences LahoreRecruiting
-
ApexCPG LLCNot yet recruitingPrimary Dysmenorrhea | Menstural CrampsIndia
Clinical Trials on pilates-based tele-exercises
-
Universidade Federal de PernambucoCompleted
-
Cairo UniversityCompletedCerebral PalsySaudi Arabia
-
Uskudar UniversityCompletedStress | Premenstrual SyndromeTurkey
-
Medical University of ViennaNeurologisches Rehabiliationszentrum RosenhügelRecruitingNeurologic DisorderAustria
-
Berna Cagla CaglayanCompleted
-
Centro Universitário Augusto MottaRecruiting
-
Pontificia Universidade Católica do Rio Grande...Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.; Fundação de Amparo... and other collaboratorsCompletedAging | Mobility Limitation | Postural BalanceBrazil
-
Michele de Aguiar ZacariaRecruiting
-
Eastern Mediterranean UniversityCompleted
-
Riphah International UniversityCompletedDepression | Sleep Quality | Primigravida FemalesPakistan